Previous Close | 6.8 |
1-Year Change | 88.89% |
6-Months Change | 48.15% |
3-Months Change | 27.1% |
Moving Avg (50d) | 6.6362 |
Moving Avg (200d) | 5.2308 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.83B |
Beta (3-Years) | 1.29 |
Revenue Growth (ttm) | 131.61% |
Net Profit Margin (ttm) | -17.72% |
Return On Assets (ttm) | -9.77% |
EPS (ttm) | -0.12 |
PE Ratio (ttm) | -56.67 |
Dividend Yield | % |
Asset Description: | MannKind Corporation |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-10-28 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
6.742 | 6.536 | 6.398 | 6.192 | 5.848 | 5.504 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |